Successful therapy of chronic graft-versus-host disease manifesting as pure red cell aplasia with single-agent rituximab

MeSH terms

• Adult
• Antibodies, Monoclonal / administration & dosage*
• Antibodies, Monoclonal, Murine-Derived
• Antineoplastic Agents / administration & dosage*
• Female
• Graft vs Host Disease / complications*
• Graft vs Host Disease / drug therapy*
• Hemoglobins / analysis
• Humans
• Lymphoma, Large B-Cell, Diffuse / therapy
• Peripheral Blood Stem Cell Transplantation / adverse effects*
• Red-Cell Aplasia, Pure / etiology*
• Remission Induction
• Reticulocyte Count
• Rituximab
• Time Factors
• Treatment Outcome